alexa Kunio Yui | Tokyo University
ISSN: 2375-4494

Journal of Child and Adolescent Behavior
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Kunio Yui

Kunio Yui Kunio Yui
Department of Cognitive-Behavioral Medicine
Tokyo University Graduate School of Medicine
Japan
Biography

Dr. Kunio Yui is now visiting researcher, Department of Cognitive-Behavioral Medicine, Tokyo University Graduate School of Medicine , where he has been since October, 2016. He was a sometime Professor of the Research Institute of Developmental Disorders at Ashiya University Graduate Sdchool of Education, where he has been since 2006. He graduated From Juntendo University , Fasculty of Medicine (Tokyo, Japan). He received a PhD. from the University of Hirosaki in 1988. From 1989 to 2005 he worked and reseached in the field of neurosciences in mental disorderes and developmental disorders in the Depatment of Pdychiatry, Jichi Medical School (Tochigi, Japan) as an assistant (1989-1995) and associate professor (1995-2005).

Research Interest

My research interests span both bilogical psychiatry andneuroscience. I published many english papers on five topics; 1) clomiphene treatment in bipolar depression related to menstration in female adolescents: 2) the role of noreadrenergic hyperactivity in spintaneous ecurrence of meth mphetasmine psychosis; 3) stress maeker in molar as predisposition of development of schizophrenia; 4) therapeutic effects of arachidonic acid suntherapeutic potential of antitumor drug everolimus in improving autism pplementation in autism and 5) therapeutic potential of antitumordrug everolimus in autism symptoms in tuberous screlosis. These dfindings are completely new and important in the medical treatmentn of mental disorders. I was given numerous invited talks and tutorials, and is a founder of and consultant to companies involved in Neuropsychopharmacology

Publications

Therapeutic Potential of Everolimus on Core Autism Symptoms and Increasing Serum Ceruloplasmin and Transferrin Levels in a Pubescent Boy with Tuberous Sclerosis
Kunio Yui, George Imataka, Toru Okanishi, Hidehiro Oka and Yohei Kawasaki
Case Report: Neonat Pediatr Med 2017, 3:128
DOI: 10.4172/2572-4983.1000128
 
Video Game Play May Attenuate Cortisol Response To Psychosocial Stress In Individuals With Autism Spectrum Disorders
Kunio Yui
Editorial: J Socialomics 2014, 1: e124
DOI: 10.4172/2167-0358.1000e124
 
Impaired Social Interaction in Autism Spectrum Disorders
Kunio Yui
Editorial: J Socialomics 2013, 2:e120
DOI: 10.4172/2167-0358.1000e120
 
Future Target of Treatment for Social Impairment of Autism Spectrum Disorders
Kunio Yui
Editorial: J Socialomics 2013, 2:e115
DOI: 10.4172/2167-0358.1000e115
 
Efficacy of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid against Restricted Repetitive Behaviors in Individuals with Autism Spectrum Disorders: A Placebo-Controlled Trial
Kunio Yui, Mamiko Koshiba, Shun Nakamura, Yuji Kobayashim and Masaki Ohnishi
Research Article: J Addict Res Ther 2011, S4
DOI: 10.4172/2155-6105.S4-006
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords